Comments on:

Amgen 4Q profit drops 16 pct. on higher spending

Back to the article » |
Drugmaker Amgen Inc. on Wednesday posted a 16 percent drop in fourth-quarter profit, as higher costs for production, marketing, research and other items offset higher sales for many of its biologic medicines. The results fell a bit short of Wall Street expectations. The world's biggest biotech company, based in Thousand Oaks, Calif., said net income was $788 million, or $1.01 per share, for...